搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Shigella dysenteriae serotype 1 Bifunctional protein HldE (hldE) CSB-YP658270SGF
CSB-EP658270SGF
CSB-BP658270SGF
CSB-MP658270SGF
CSB-EP658270SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 tRNA-modifying protein ygfZ (ygfZ) CSB-YP658271SGF
CSB-EP658271SGF
CSB-BP658271SGF
CSB-MP658271SGF
CSB-EP658271SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Phosphoglycerate kinase (pgk) CSB-YP658272SGF
CSB-EP658272SGF
CSB-BP658272SGF
CSB-MP658272SGF
CSB-EP658272SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Probable Fe (2+)-trafficking protein (yggX) CSB-YP658273SGF
CSB-EP658273SGF
CSB-BP658273SGF
CSB-MP658273SGF
CSB-EP658273SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Thymidylate synthase (thyA) CSB-YP658274SGF
CSB-EP658274SGF
CSB-BP658274SGF
CSB-MP658274SGF
CSB-EP658274SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 23S rRNA (uracil (1939)-C (5))-methyltransferase RlmD (rlmD) CSB-YP658275SGF
CSB-EP658275SGF
CSB-BP658275SGF
CSB-MP658275SGF
CSB-EP658275SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Adenylyl-sulfate kinase (cysC) CSB-YP658276SGF
CSB-EP658276SGF
CSB-BP658276SGF
CSB-MP658276SGF
CSB-EP658276SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Nitric oxide reductase FlRd-NAD (+) reductase (norW) CSB-YP658277SGF
CSB-EP658277SGF
CSB-BP658277SGF
CSB-MP658277SGF
CSB-EP658277SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Glutamate--cysteine ligase (gshA), partial CSB-YP658278SGF
CSB-EP658278SGF
CSB-BP658278SGF
CSB-MP658278SGF
CSB-EP658278SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 GTPase Era (era) CSB-YP658279SGF
CSB-EP658279SGF
CSB-BP658279SGF
CSB-MP658279SGF
CSB-EP658279SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Probable inorganic polyphosphate/ATP-NAD kinase (ppnK) CSB-YP658280SGF
CSB-EP658280SGF
CSB-BP658280SGF
CSB-MP658280SGF
CSB-EP658280SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Serine hydroxymethyltransferase (glyA) CSB-YP658281SGF
CSB-EP658281SGF
CSB-BP658281SGF
CSB-MP658281SGF
CSB-EP658281SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Nucleoside diphosphate kinase (ndk) CSB-YP658282SGF
CSB-EP658282SGF
CSB-BP658282SGF
CSB-MP658282SGF
CSB-EP658282SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 DnaA-homolog protein hda (hda) CSB-YP658283SGF
CSB-EP658283SGF
CSB-BP658283SGF
CSB-MP658283SGF
CSB-EP658283SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Acetyltransferase YpeA (ypeA) CSB-YP658284SGF
CSB-EP658284SGF
CSB-BP658284SGF
CSB-MP658284SGF
CSB-EP658284SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Glutamate--tRNA ligase (gltX) CSB-YP658285SGF
CSB-EP658285SGF
CSB-BP658285SGF
CSB-MP658285SGF
CSB-EP658285SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 Penicillin-insensitive murein endopeptidase (mepA) CSB-YP658286SGF
CSB-EP658286SGF
CSB-BP658286SGF
CSB-MP658286SGF
CSB-EP658286SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 NADH-quinone oxidoreductase subunit B (nuoB) CSB-YP658287SGF
CSB-EP658287SGF
CSB-BP658287SGF
CSB-MP658287SGF
CSB-EP658287SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 o-succinylbenzoate synthase (menC) CSB-YP658288SGF
CSB-EP658288SGF
CSB-BP658288SGF
CSB-MP658288SGF
CSB-EP658288SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella dysenteriae serotype 1 UPF0145 protein YbjQ (ybjQ) CSB-YP658289SGF
CSB-EP658289SGF
CSB-BP658289SGF
CSB-MP658289SGF
CSB-EP658289SGF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>